Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03451864
Other study ID # 29
Secondary ID
Status Completed
Phase N/A
First received February 25, 2018
Last updated February 25, 2018
Start date September 1, 2016
Est. completion date February 24, 2018

Study information

Verified date February 2018
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Eighty-eight pregnant women and their newborns were enrolled in a cross-sectional study. Maternal serum 25-OHD was measured by ELISA


Description:

Eighty-eight pregnant women and their newborns were enrolled in a cross-sectional study. Maternal serum 25-OHD was measured by ELISA.Maternal 25 (OH) vitamin D measurement: Blood samples for determination of serum 25 (OH) vitamin D were collected by venipuncture and processed as follows: 3 mL blood were collected into plain tubes and allowed to clot for 30 minutes, then it was centrifuged at 1500 round per minute for 15 minutes at room temperature and the serum was separated into clean, properly labeled tubes and stored at ≤ -20°C till assay. Serum 25 (OH) vitamin D level was assessed by Enzyme-Linked ImmunoSorbent Assay (ELISA) using DRG 25-OH Vitamin D (total) ELISA (DRG International, Inc., USA) according to manufacturer's instructions. Vitamin D deficiency is defined by 25(OH) D levels less than 20 ng/d


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date February 24, 2018
Est. primary completion date February 1, 2018
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- Healthy women Term pregnancy

Exclusion Criteria:

any chronic illness as chronic hypertension or pregestational diabetes pregnancy-related illnesses as preeclampsia, gestational diabetes multiple pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Vaginal delivery
classic vaginal delivery
Cesarean Section
routine lower segment cesarean scetion

Locations

Country Name City State
Egypt Kasr Alainy medical school Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neonatal intensive care unit admission Admission of the neonate to NICU 24 hours after delivery
See also
  Status Clinical Trial Phase
Completed NCT01261689 - The Randomised Epidural Analgesia in Term Delivering Women Trial (TREAT) N/A
Completed NCT03148717 - Preoperative vs. Postoperative Rectal Misoprostol in Cesarean Section Phase 2/Phase 3
Recruiting NCT04766866 - sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term. N/A
Completed NCT03008577 - Hypothermia and the Effect of Ambient Temperature 2 N/A
Completed NCT00580268 - Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity N/A